CRA-13

[mjhealthtips]

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract Cannabinoid Receptor Agonist 13, a Novel Cannabinoid Agonist: First in Human Pharmacokinetics and Safety (full – 2009)http://dmd.aspetjournals.org/content/37/4/827.full Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19280324